Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces that ...

Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, today ...

As a global leader in neuroscience, Neuronetics is delivering more treatment options to patients and physicians by offering exceptional in-office treatments that produce extraordinary results.

Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage company developing product candidates designed to treat neurodegenerative disorders, announced that the Company’s president and CEO, Lisa ...

FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Syncromune®, Inc., a clinical-stage biopharmaceutical company pioneering SYNC-T, an in situ personalized combination ...

Entering a catalyst-rich period, Novartis expects 15+ potentially submission-enabling readouts over the next two years. With significant replacement power and a robust pipeline featuring 30+ potential ...

With a holistic and adaptive cyber resilience plan, Renown Health aligns information security and technology innovations to ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

Operator: Good morning, and thank you for standing by. Currently, all of the participants are in listen only mode. After ...

Background Eisenmenger syndrome (ES) is a severe and fatal complication of uncorrected congenital heart disease characterised ...

Kingsoft Cloud Holdings Limited (NASDAQ: KC) Q3 2025 Earnings Call Transcript November 19, 2025 Kingsoft Cloud Holdings ...

Artificial intelligence is only as strong as the data behind it. Healthcare leaders are working with their teams to build the infrastructure, governance, and culture necessary to support AI at scale.